Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$25,702
New position
Shares Held
164
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,480
of 1,602 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlatl Advisers LLC holds $803,426 across 11 Drug Manufacturers - General names. NVS ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,186 | $301,208 | |
| 2 | LLY |
ELI LILLY & Co
|
115 | $137,934 | |
| 3 | ABBV |
AbbVie Inc.
|
548 | $137,898 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
427 | $53,947 | |
| 5 | MRK |
Merck & Co., Inc.
|
399 | $51,271 | |
| 6 | AMGN |
Amgen Inc
|
105 | $38,022 | |
| 7 | AZN |
Astrazeneca PLC
|
191 | $36,217 | |
| 8 | NVS |
Novartis AG
This page
|
164 | $25,702 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,702 | 164 | Shares | Sole | 2026-07-22 | |
| No filing history on record for this holder in this stock. | ||||||